MANNKIND CORP
Biopharmaceutical firm developing inhaled therapies for cardiometabolic/orphan lung diseases.
MNKD | US
Overview
Corporate Details
- ISIN(s):
- US56400P7069
- LEI:
- Country:
- United States of America
- Address:
- 1 CASPER STREET, 6810 DANBURY
- Website:
- https://mannkindcorp.com/
- Sector:
- Manufacturing
Description
MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products and devices. The company specializes in inhaled therapies for patients with cardiometabolic and orphan lung diseases. Its portfolio includes Afrezza®, an inhaled insulin for diabetes, and Tyvaso DPI®, a dry powder inhaler for pulmonary hypertension developed in collaboration with United Therapeutics. Through its acquisition of scPharmaceuticals, MannKind also markets FUROSCIX®, a subcutaneous treatment for edema in adults with chronic heart failure. The company's pipeline is focused on expanding indications for its existing products, including a pediatric application for Afrezza.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-12 17:26 | English | 7.2 KB | |||
| 2025-12-05 01:32 |
4
|
English | 7.4 KB | ||
| 2025-12-05 01:27 |
4
|
English | 7.6 KB | ||
| 2025-12-02 22:24 | English | 6.8 KB | |||
| 2025-12-02 22:23 | English | 6.9 KB | |||
| 2025-11-15 02:00 |
4
|
English | 6.7 KB | ||
| 2025-11-14 22:02 | English | 6.7 KB | |||
| 2025-11-13 02:00 |
4
|
English | 6.6 KB | ||
| 2025-11-10 14:05 |
8-K
|
English | 52.8 KB | ||
| 2025-11-05 14:06 |
10-Q
|
English | 3.5 MB | ||
| 2025-11-05 14:03 |
8-K
|
English | 186.1 KB | ||
| 2025-11-04 02:16 |
4
|
English | 6.5 KB | ||
| 2025-10-10 03:13 |
3
|
English | 5.6 KB | ||
| 2025-10-09 23:17 |
8-K
|
English | 178.7 KB | ||
| 2025-09-18 01:39 |
4
|
English | 6.9 KB |
Automate Your Workflow. Get a real-time feed of all MANNKIND CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MANNKIND CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MANNKIND CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
